1. Guarner F, Casellas F, Borruel N et al (2002) Role of microecology in chronic inflammatory bowel diseases. Eur J Clin Nutr 56(Suppl 4):S34-S38

2. Duchmann R, Kaiser I, Hermann E et al (1995) Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 102:104-108

3. MacPherson A, Khoo UY, Forgacs I et al (1996) Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38:365-375

4. Janowitz HD, Croen EC, Sachar DB (1998) The role of the faecal stream in Crohn's disease: an historical and analytic perspective. Inflamm Bowel Dis 4:29-39

5. D'Haens GR, Geboes K, Peeters M et al (1998) Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gas-troenterology 114:771-774

6. Neut C, Bulois P, Desreumaux P et al (2002) Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol 97:939-946

7. Sartor RB (1995) Insights into the pathogenesis of inflammatory bowel disease provided by new rodent models of spontaneous colitis. Inflam Bowel Dis 1:64-75

8. Campieri M, Gionchetti P( 1999) Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative? Gastroenterology 116:1246-1249

9. Metchnikoff E (1907) The prolongation of life: optimistic studies. Heinemann, London, pp 161-183

10. Schaafsma G (1996) State of the art concerning probiotic strains in milk products. IDF Nutr News l5:23-42

11. Lee YK, Salminen S (1995) The coming age of probiotics. Trends Food Sci Technol 6:241-245

12. Fabia R, Ar'rajab A, Johansson M-L et al (1993) The effect of exogenous administration of Lactobacillus reuterii R2LC and oat fiber on acetic acid-induced colitis in the rat. Scand J Gastroenterol 28:155-162

13. Mao Y, Nobaek S, Kasravi B et al (1996) The effects of Lactobacillus strains and oat fibre on methotrexate-induced enterocolitis in rats. Gastroenterology 111:334-344

14. Madsen KL, Tavernini MM, Doyle JSG, Fedorak RN (1999) Lactobacillus sp prevents development of enterocolitis in interleukin-10 gene-deficient mice. Gastroenterology 116:1107-1114

15. Schultz M, Veltkamp C, Dieleman LA et al (2002) Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10 deficient mice. Inflamm Bowel Dis 8:71-80

16. O'Mahony L, Feenex M, O'Halloran S et al (2001) Pro-biotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment Pharmacol Ther 15:1219-1225

17. McCarthy J, O'Mahony L, O'Callaghan L et al (2003) Double-blind, placebo-controlled trial of two probiot-ic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 52:975-980

18. Shibolet O, Karmeli F, Eliakim R et al (2002) Variable response to probiotics in two models of experimental colitis in rats. Inflamm Bowel Dis 8:399-408

19. Madsen K, Cornish A, Soper P et al (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121:580-591

20. Kruis W, Schuts E, Fric P (1997) Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 11:853-858

21. Rembacken BJ, Snelling AM, Hawkey P (1999) Non pathogenic Escherichia coli vs mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354:635-639

22. Kruis W, Fric P, Potrotnieks J et al (2004)Maintaining remission of ulcerative colitis with Escherichia Coli Nissle 1917 is as effective as with standard mesalazine. Gut 53:1673-1623

23. Venturi A, Gionchetti P, Rizzello F et al (1999) Impact on the faecal flora composition of a new probiotic preparation. Preliminary data on maintenance treatment of patients with ulcerative colitis (UC) intolerant or allergic to 5-aminosalicylic acid (5 ASA). Aliment Pharmacol Ther 13:1103-1108

24. Bibiloni R, Federak RN, Tannock GW et al (2005) VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. AM J Gastroen-terol 100(7):1539-1546

25. Guslandi M, Giollo P, Testoni PA (2003) A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol 15:697-698

26. Gionchetti P, Rizzello F, Venturi A et al (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119:305-309

27. Mimura t, Rizzello F, Helwig U et al (2004) Once daily high dose probiotic therapy for maintaining remission in recurrent or refractory pouchitis. Gut 53:108-114

28. Ulisse S, Gionchetti P, D'AlcS et al (2001) Increased expression of cytokines, inducible nitric oxide synthase and matrix metalloproteinases in pouchitis: effects of probiotic treatment (VSL#3). Gastroenterology 120(Suppl):A281

29. Kuisma J, Mentula S, Kahri A et al (2003) Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment Pharmacol Ther 17:509-515

30. Gionchetti P, Rizzello F, Venturi A et al (2000) Prophylaxis of pouchitis onset with probiotic therapy: a double blind, placebo controlled trial. Gastroenterolo-gy 118:A190

31. Malchow HA (1997) Crohns disease and Escherichia coli. a new approach in therapy to maintain remission of colonic Crohns disease? J Clin Gastroenterol 25:653-658

32. Guslandi M, Mezzi G, Sorghi M et al (2000) Saccha-romyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 45:1462-1464

33. Prantera C, Scribano ML, Falasco G et al (2002) Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 51:405-409

34. Bousvaros A, Guandalini S, Baldassano RN et al (2005)A randomised, double-blind trial of Lactobacil-lus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis 11:833-839

35. Campieri M, Rizzello F, Venturi A et al (2000) Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohns disease: a randomised controlled study vs. mesalazine. Gastroenterology 118:A781

Was this article helpful?

0 0
Mole Removal

Mole Removal

Moles, warts, and other unsightly irregularities of the skin can be bothersome and even embarrassing. They can be removed naturally... Removing Warts and Moles Naturally! If you have moles, warts, and other skin irregularities that you cannot cover up affecting the way you look, you can have them removed. Doctors can be extremely expensive. Learn the natural ways you can remove these irregularities in the comfort of your own home.

Get My Free Ebook

Post a comment